Back to Awarded Treatment Trials
Awarded Trial: 05-RC-001-1
Grant ID
05-RC-001-1
Illness
Schizophrenia
Primary Drug/Intervention
Atomoxetine
Primary Dosage
80 mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Tamminga
Sample Size
60
Duration of Study Period for Each Subject
8 weeks
Outcome Measurements
PANSS, CGI, Barnes Akathisia Scale, Simpson Angus Scales, Cognitive Battery
Results
N/A
Publication
N/A
Link
N/A
PI Name
Carol Tamminga
Degree
MD
Center
Department of Psychiatry
Institution
UT Southwestern Medical Center
Address
5323 Harry Hines Boulevard
City or Town
Dallas
State or Province
TX
Zip or Postal Code
75390
Country
USA
Email Address
carol.tamminga@utsouthwestern.edu